Pfizer's Litfulo Scores FDA Approval As First Alopecia Treatment For Adolescents

The FDA approved Pfizer Inc's (NYSE: PFE) Litfulo (ritlecitinib), an oral treatment for severe alopecia areata in individuals 12 and older.

Litfulo is the first and only FDA-approved treatment for adolescents (12+) with severe alopecia areata.